15th Annual Hepatology Symposium

High Impact Hepatology:
An Update from the Major Liver Meetings

Saturday, November 4, 2017
Rizzo Conference Center, Chapel Hill, NC
Jointly Provided by Mountain AHEC and the UNC Liver Center
Co-sponsored by UNC Eschelman School of Pharmacy

MAHEC UNC Eshelman School of Pharmacy

Saturday, November 4

8:00am – 8:10am

Welcome and Introduction

Session I:

8:30am – 8:50am

NASH Therapeutics and Novel Diagnostic Modalities
Sid Barritt, MD, MSCR

8:50am – 9:10am

Something Old, Something New: Management of Portal Vein Thrombosis
Paul Hayashi, MD, MPH

9:10am to 9:30am

Going the Last Mile: Latest HCV regimens
Michael Fried, MD

9:30am – 9:50am

Debunking the Cochrane Report: Long-term Outcomes in HCV and Monitoring Post-SVR
Michael Fried, MD

9:50am – 10:20am

Break/Poster Viewing/Exhibits

Session II:

10:20am – 10:40am

Utilizing HCV+ organs in HCV negative recipients
Raj Reddy, MD
Director of Hepatology
Hospital of the University of Pennsylvania

10:40am – 11:00am

Kinase Inhibitors and Immunotherapies for HCC
Hanna Sanoff, MD, MPH
GI Medical Oncolology, UNC

11:00am – 11:20am

Complications of Portal Hypertension: New Approaches
Steven Zacks, MD, MPH

11:20am – 11:40am

Cholestatic Liver Disease: Beyond URSO
Jama Darling, MD

11:40am – 12:45pm

Case Discussions (w/Learning Lunch)
Jama Darling, MD

Session III:

12:45pm – 1:05pm

Liver Disease and Pregnancy
Richard Sterling, MD
Virginia Commonwealth University Medical Center

1:05pm – 1:25pm

Initial Management of Acute Liver Failure
Richard Sterling, MD
Virginia Commonwealth University Medical Center

1:25pm – 1:45pm

On the Run? Prospects for Cure of HBV
Jama Darling, MD

1:45pm – 2:00pm

Discussion and Wrap-up